Toll-like receptor 2-mediated sequential activation of MyD88 and MAPKs contributes to lipopolysaccharide-induced sp-a gene expression in human alveolar epithelial cells

Immunobiology

Volumn 216, Issue 6, 2011, Pages 707-714

  Chuang, Chi Yuan ^a,b   Chen, Tyng Guey ^a   Tai, Yu Tyng ^a   Chen, Ta Liang ^a   Lin, Yu Hua ^a   Tsai, Cheng Hsiu ^a   Chen, Ruei Ming ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Acute lung injury; Alveolar epithelial cells; Lipopolysaccharide; MyD88 MEK4 JNK1 AP 1; Surfactant protein A; Toll like receptor 2

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN C FOS; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; PNEUMOCYTES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP-1;

EID: 79955531610     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.10.009     Document Type: Article

References (37)

1. Akira S., Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling. J. Infect. Dis. 2003, 187:S356-S363.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
4. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
5. Bysani G.K., Shenep J.L., Hildner W.K., Stidham G.L., Roberson P.K. Detoxification of plasma containing lipopolysaccharide by adsorption. Crit. Care Med. 1990, 18:67-71.
6. Chang H.C., Chen T.L., Chen R.M. Interruption of hepatocyte cytoskeletons by ketamine occurs through suppression of calcium mobilization and mitochondrial function. Drug Metab. Dipos. 2009, 37:24-31.
7. Chiu W.T., Lin Y.L., Chou C.W., Chen R.M. Propofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFκB. Chem. Biol. Interact. 2009, 181:430-439.
8. Chuang C.Y., Chen T.L., Chen R.M. Molecular mechanisms of lipopolysaccharide-caused induction of surfactant protein-A gene expression in human alveolar epithelial A549 cells. Toxicol. Lett. 2009, 191:132-139.
9. Crouch E.C. Collectins and pulmonary host defense. Am. J. Respir. Cell. Mol. Biol. 1998, 19:177-201.
10. Dillon S., Agrawal A., van Dyke T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., Pulendran B. A toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 2004, 172:4733-4743.
11. Droemann D., Goldmann T., Branscheid D., Clark R., Dalhoff K., Zabel P., Vollmer E. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem. Cell Biol. 2003, 119:103-108.
12. Fan H., Peck O.M., Tempel G.E., Halushka P.V., Cook J.A. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NF-kappa B activation. Shock 2004, 22:57-62.
13. Flood D.G., Finn J.P., Walton K.M., Dionne C.A., Contreras P.C., Miller M.S., Bhat R.V. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J. Comp. Neurol. 1998, 398:373-392.
14. Gunther A., Siebert C., Schmidt R., Ziegler S., Grimminger F., Yabut M., Temmesfeld B., Walmrath D., Morr H., Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 1996, 153:176-184.
15. Gunther A., Ruppert C., Schmidt R., Markart P., Grimminger F., Walmrath D., Seeger W. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2001, 2:353-364.
16. Hess J., Angel P., Schorpp-Kistner M.L. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004, 117:5965-5973.
17. Jeyaseelan S., Young S.K., Fessler M.B., Liu Y., Malcolm K.C., Yamamoto M., Akira S., Worthen G.S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol. 2007, 178:3153-3160.
18. Kaisho T., Akira S. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 2002, 1589:1-13.
19. Khubchandani K.R., Snyder J.M. Surfactant protein A (SP-A): the alveolus and beyond. FASEB J. 2001, 15:59-69.
20. Knapp S., Florquin S., Golenbock D.T., van der Poll T. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J. Immunol. 2006, 176:3189-3195.
21. Lee S.T., Wu T.T., Yu P.Y., Chen R.M. Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br. J. Anaesth. 2009, 102:80-89.
22. Lee C.J., Tai Y.T., Lin Y.L., Chen R.M. Molecular mechanisms of propofol-involved suppression of nitric oxide biosynthesis and inducible nitric oxide synthase gene expression in lipopolysaccharide-stimulated macrophage-like Raw 264.7 cells. Shock 2010, 33:93-100.
23. LeVine A.M., Whitsett J.A., Gwozdz J.A., Richardson T.R., Fisher J.H., Burhans M.S., Korfhagen T.R. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 2000, 165:3934-3940.
24. Lin M.W., Tsao L.T., Chang L.C., Chen Y.L., Huang L.J., Kuo S.C., Tzeng C.C., Lee M.R., Wang J.P. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochem. Pharmacol. 2007, 73:1796-1806.
25. Mendelson C.R. Role of transcription factors in fetal lung development and surfactant protein gene expression. Ann. Rev. Physiol. 2000, 62:875-915.
26. Miakotina O.L., Snyder J.M. Signal transduction events involved in TPA downregulation of SP-A gene expression. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286:L1210-L1219.
27. O'Neill L.A., Dunne A., Edjeback M., Gray P., Jefferies C., Wietek C. Mal and MyD88: adapter proteins involved in signal transduction by toll-like receptors. J. Endotoxin Res. 2003, 9:55-59.
28. Potapova O., Basu S., Mercola D., Holbrook N.J. Protective role for c-Jun in the cellular response to DNA damage. J. Biol. Chem. 2001, 276:28546-28553.
29. Raetz C.R., Ulevitch R.J., Wright S.D., Sibley C.H., Ding A., Nathan C.F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991, 5:2652-2660.
30. Rooney S.A. Regulation of surfactant secretion. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2001, 129:233-243.
31. Satta N., Kruithof E.K., Reber G., de Moerloose P. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Mol. Immunol. 2008, 46:45-157.
32. Slevogt H., Zabel S., Opitz B., Hocke A., Eitel J., N'guessan P.D., Lucka L., Riesbeck K., Zimmermann W., Zweigner J. CEACAM1 inhibits toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat. Immunol. 2008, 9:1270-1278.
33. Wolska A., Lech-Maranda E., Robak T. Toll-like receptors and their role in hematologic malignancies. Curr. Mol. Med. 2009, 9:324-335.
34. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
35. Wu G.J., Chen T.L., Ueng Y.F., Chen R.M. Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol. Appl. Pharmacol. 2008, 228:105-113.
36. Wu G.J., Chen T.L., Chang C.C., Chen R.M. Propofol suppresses tumor necrosis factor-α biosynthesis in lipopolysaccharide-stimulated macrophages possibly through downregulation of nuclear factor-kappa B-mediated toll-like receptor 4 gene expression. Chem. Biol. Interact. 2009, 180:465-471.
37. Zahringer U., Lindner B., Inamura S., Heine H., Alexander C. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008, 213:205-224.